Adamax
Adamax is sold as a modified Semax analogue. No research on it has been published — not in people, not in animals, not in cells.
Regulatory status: Not a medicine and not a studied compound. It is a research chemical with no literature behind it.
Default vial
10 mg
Default mix
2 mL
Reported range
No published human dose
Draw (U-100)
6 u
A PubMed search returns no research on this compound at all. Vendor pages describe it as a modified Semax analogue, but they do not agree on its structure, and the claims made for it rest on Semax studies rather than on anything published about Adamax.
Where these numbers come from
No study of this compound has been published, so there is no dose to cite and nothing to base one on. The figures here exist only so the calculator can run — they are not a recommendation and are not drawn from any source.
Reviewed October 2026
What it is
- Described by vendors as Semax with an adamantane group attached, intended to make it more stable and better at reaching the brain.
- Vendor descriptions do not agree with each other about what the molecule actually is — some describe a Semax derivative, others something different — which is itself a reason for caution.
- No established route, schedule or dose.
- Sold as a research compound.
How it is described to act
- 1
Nothing is published about how this compound is absorbed, distributed, metabolised or cleared.
- 2
The adamantane modification is a real chemical strategy for improving stability, but its effect on this molecule has not been characterised in any published work.
- 3
No mechanism has been demonstrated. The mechanisms described for it in marketing are Semax's.
- 4
No outcome has been measured, in any species.
What the research has looked at
Published research on Adamax
- There is none. A PubMed search returns no studies of this compound.
- The cognitive and BDNF claims made for it come from research on Semax, a different molecule. A structural modification can change potency, selectivity, duration and toxicity, so those findings do not transfer.
- Adding an adamantane group introduces a chemical feature with biological activity of its own, and that has not been characterised here.
Strength of evidence: No published research
No study of this compound has been published. Pep-Tidy lists it because people are sold it, not because there is anything to report about it.
A search of the published literature returns nothing for this compound — no human trials, no animal studies, no cell work. Claims made about it elsewhere are not drawn from published research on this molecule.
Reported cautions and unknowns
- Nothing is known about its safety, because nothing has been published.
- With no published analysis of the molecule, there is also no independent check that what is sold under this name is the same thing from one supplier to the next.
- Claims of safety based on Semax's record describe a different compound.
References
There are none. A search of the published literature returns no studies of this compound — no human trials, no animal work, no cell studies. Anything claimed about it elsewhere is not drawn from published research on this molecule.
Handling this vial
- Lyophilized vials are generally stored at 2–8 °C and kept out of light; once reconstituted with bacteriostatic water they are refrigerated and commonly discarded after 28 days.
- Mix by aiming water down the vial wall and rolling gently — do not shake — and never re-freeze a reconstituted vial.
- Pep-Tidy cannot verify what is in your vial. Ask your supplier for a current Certificate of Analysis (HPLC/MS).
Adamax questions people ask
How do you reconstitute Adamax?
A common starting point for a 10 mg vial of Adamax is 2 mL of bacteriostatic water, which gives 5 mg per mL. Aim the water down the inside wall of the vial, let it dissolve on its own, and roll gently instead of shaking. Pep-Tidy's reconstitution calculator will recalculate the numbers for any other vial size or water volume you use.
How many units of Adamax is one dose?
At 5 mg per mL, that works out to about 6 units on a U-100 insulin syringe for a 300 mcg dose. Change the vial size, water volume, or target dose in the calculator and the syringe reading updates with it. This is arithmetic, not a dosing recommendation.
What dosing schedule is reported for Adamax?
Published and community sources describe No published human dose, intranasal, every day, typically run 4 weeks on and 2 weeks off. These figures describe what has been reported, not what anyone should take — talk to a licensed clinician first.
How should Adamax be stored?
Lyophilized Adamax vials are generally kept at 2–8 °C and out of light. Once reconstituted with bacteriostatic water they are refrigerated and commonly discarded after about 28 days. Never re-freeze a reconstituted vial and never shake it.
Read this before you act on anything above
Everything on this page is a summary of what other people have published — it is not medical advice, not a recommendation, and not a dosing instruction. Reported dose ranges describe what appears in the literature or in community protocols, not what anyone should take. Talk to a licensed clinician before using any peptide.